Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined \"one of the most well-known studies supported by the NIHR with clear national and global impact.\u201d
Thanks to cutting edge research at NDM's Jenner Institute and Oxford University Clinical Research Unit (OUCRU), Oxford remains at the forefront of research to develop new vaccines to protect against this devastating disease.
In a recent study, researchers at the KEMRI Wellcome Trust Research Programme in Kenya have discovered that a low-dose of the yellow fever vaccine is as effective as the current standard dose.
Scientists have found another clue about how brain health is maintained and how this might be affected by ageing and Alzheimer\u2019s disease, according to a new paper.
Researchers have published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
Researchers have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies. New antibody therapies could offer alternative to current treatments.
The Mastercard Foundation Scholars at Oxford's Africa Oxford Initiative receive full scholarships, rigorous education, leadership training, entrepreneurship support and networking, preparing them to lead Africa's and the world's future challenges and opportunities.
The Goding lab, working in collaboration with the University Rey Juan Carlos, have shown that fatty acid uptake activates an AXL-CAV1-\u03b2-catenin axis to drive melanoma invasiveness.
A landmark study involving researchers from NDM\u2019s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
The Ineos Oxford Institute for antimicrobial research (IOI) has awarded \u00a35 million to a group of interdisciplinary researchers from NDM and other departments at the University, to develop new therapies for drug-resistant tuberculosis.
After more than a year of community engagement and preparation in 100 villages with over 12,000 inhabitants across the Chittagong Hill Tracts, a mass malaria vaccine (R21/Matrix M) and drug administration (DHA, piperaquine, and single low dose primaquine) study was launched on 15 February.
In the first study of this kind, NDM\u2019s Pandemic Sciences Institute and Oxford researchers partner with global colleagues to outline how artificial intelligence can transform infectious disease research and save more lives.
A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.
A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.
NDM\u2019s Pandemic Sciences Institute and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics \u2013 as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Five members of the MSc Genomic Medicine teaching team have been awarded Advanced HE fellowships in recognition of their roles in teaching and supporting higher education learning.
International Day of Women and Girls in Science serves as a reminder of the gender disparities that persist in the Science, Technology, Engineering and Mathematics (STEM) fields.
![\"\"](\"https://www.ndm.ox.ac.uk/news/recovery-trial-team-win-nihr-impact-prize/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n